Acute Market Reports pharmaceuticals report, Axitinib (Renal Cell Carcinoma)- Analysis and Forecasts to 2020 provides Axitinib sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020).
For More Information visit: http://www.acutemarketreports.com/report/axitinib-renal-cell-carcinoma-analysis-and-forecasts-to-2020
The report also includes information on Renal Cell Carcinoma market. This report is built using data and information sourced from Acute Market Reports prorietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.
Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.
Scope
Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
Analysis and review of Axitinib including historical sales data
Qualitative and quantitative assessment of market space
Analysis of the trends, drivers and restraints shaping and defining the markets
In-depth analysis of Axitinib including efficacy, safety, pricing, competition and other details which influence its sales potential
Detailed sales forecast for 2012-2020 for Axitinib in each of the seven major markets
Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
Analysis and review of Axitinib including historical sales data
Qualitative and quantitative assessment of market space
Analysis of the trends, drivers and restraints shaping and defining the markets
In-depth analysis of Axitinib including efficacy, safety, pricing, competition and other details which influence its sales potential
Detailed sales forecast for 2012-2020 for Axitinib in each of the seven major markets
Reasons to buy
Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of the drugs performance
Examine the historical sales performance of a drug in seven major markets
Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of the drugs performance
Examine the historical sales performance of a drug in seven major markets
Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Click Here To Download Detail Report: http://www.acutemarketreports.com/request-free-sample/36925
1 Table of contents 2
1.1 List of Tables 3
1.2 List of Figures 3
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 5
2.1 RCC Market 5
2.2 Epidemiology 5
2.3 Etiology 7
2.3.1 Tobacco 7
2.3.2 Obesity 7
2.3.3 Acquired Cystic Disease 8
2.3.4 Hypertension 8
2.4 GlobalData Pipeline Report Guidance 8
2.1 RCC Market 5
2.2 Epidemiology 5
2.3 Etiology 7
2.3.1 Tobacco 7
2.3.2 Obesity 7
2.3.3 Acquired Cystic Disease 8
2.3.4 Hypertension 8
2.4 GlobalData Pipeline Report Guidance 8
3 RCC Disease: Market Characterization 9
3.1 RCC Disease Market 9
3.2 RCC Disease Market Forecasts and CAGR 9
3.3 Drivers for the RCC Disease Market 9
3.3.1 High Incidence 10
3.3.2 High Prevalence 11
3.3.3 Emergence of Targeted Therapies 11
3.3.4 Large Unmet Need 11
3.1 RCC Disease Market 9
3.2 RCC Disease Market Forecasts and CAGR 9
3.3 Drivers for the RCC Disease Market 9
3.3.1 High Incidence 10
3.3.2 High Prevalence 11
3.3.3 Emergence of Targeted Therapies 11
3.3.4 Large Unmet Need 11
4 Tumor-Node-Metastases (TNM) Classification of RCC 12
View all reports of this category @ http://www.acutemarketreports.com/category/renal-cell-carcinoma-market
5 Axitinib 15
5.1 Introduction 15
5.2 Mechanism of Action 15
5.3 Clinical Studies 15
5.4 Sales drivers 16
5.4.1 Renal cancer Market 16
5.4.2 Better Efficiency 16
5.4.3 Manageable Toxicity 16
5.4.4 Increased Median Survival 16
5.4.5 Better Efficacy 17
5.5 Drug Evaluation 17
5.5.1 Drug Risk Benefit Score 17
5.5.2 Intensity of Competition 18
5.6 Sales forecast 19
5.6.1 Target patient Pool of Axitinib 19
5.6.2 Market Penetration 20
5.6.3 Dosing 21
5.6.4 Annual Cost of Therapy 21
5.6.5 Sales Projections of Axitinib 21
5.1 Introduction 15
5.2 Mechanism of Action 15
5.3 Clinical Studies 15
5.4 Sales drivers 16
5.4.1 Renal cancer Market 16
5.4.2 Better Efficiency 16
5.4.3 Manageable Toxicity 16
5.4.4 Increased Median Survival 16
5.4.5 Better Efficacy 17
5.5 Drug Evaluation 17
5.5.1 Drug Risk Benefit Score 17
5.5.2 Intensity of Competition 18
5.6 Sales forecast 19
5.6.1 Target patient Pool of Axitinib 19
5.6.2 Market Penetration 20
5.6.3 Dosing 21
5.6.4 Annual Cost of Therapy 21
5.6.5 Sales Projections of Axitinib 21
6 RCC Market: Appendix 31
6.1 Market Definitions 31
6.2 Abberiviations 31
6.3 Research Methodology 31
6.3.1 Coverage 32
6.3.2 Secondary Research 32
6.3.3 Forecasting 32
6.3.4 Number of Patients Approved to take the Drug 33
6.3.5 Net Penetration of Drug 33
6.3.6 Net Annual Dosing 35
6.3.7 Annual Cost of Therapy 35
6.3.8 Primary Research 35
6.3.9 Expert Panels 35
6.4 Contact Us 35
6.5 Disclaimer 36
6.6 Sources 36
6.1 Market Definitions 31
6.2 Abberiviations 31
6.3 Research Methodology 31
6.3.1 Coverage 32
6.3.2 Secondary Research 32
6.3.3 Forecasting 32
6.3.4 Number of Patients Approved to take the Drug 33
6.3.5 Net Penetration of Drug 33
6.3.6 Net Annual Dosing 35
6.3.7 Annual Cost of Therapy 35
6.3.8 Primary Research 35
6.3.9 Expert Panels 35
6.4 Contact Us 35
6.5 Disclaimer 36
6.6 Sources 36
Latest Report: http://www.fpt2013.org/s-1-pancreatic-cancer-market/
About Us:
About Us:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.
Our market research professionals have detailed knowledge of the publishers and different kinds of reports in their particular business domains. They will guide you in finding the complete range of available market research reports, review the scope and procedure of the research studies that you select, and provide you guidance in order to assist you in taking the correct business decisions related to the purchase of the market research reports.
Acute Market Reports
Mr. Chris Paul
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Website: Acute Market Reports
Mr. Chris Paul
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Website: Acute Market Reports
No comments:
Post a Comment